CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 150 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $39,000 | +62.5% | 19,588 | 0.0% | 0.00% | – |
| Q4 2020 | $24,000 | -31.4% | 19,588 | 0.0% | 0.00% | – |
| Q3 2020 | $35,000 | -78.7% | 19,588 | 0.0% | 0.00% | – |
| Q2 2020 | $164,000 | +105.0% | 19,588 | +27.6% | 0.00% | – |
| Q1 2020 | $80,000 | -4.8% | 15,355 | 0.0% | 0.00% | – |
| Q4 2019 | $84,000 | +12.0% | 15,355 | 0.0% | 0.00% | – |
| Q3 2019 | $75,000 | -29.2% | 15,355 | 0.0% | 0.00% | – |
| Q2 2019 | $106,000 | +1.0% | 15,355 | +1.7% | 0.00% | – |
| Q1 2019 | $105,000 | +19.3% | 15,105 | 0.0% | 0.00% | – |
| Q4 2018 | $88,000 | -22.8% | 15,105 | 0.0% | 0.00% | – |
| Q3 2018 | $114,000 | +50.0% | 15,105 | 0.0% | 0.00% | – |
| Q2 2018 | $76,000 | -17.4% | 15,105 | 0.0% | 0.00% | – |
| Q1 2018 | $92,000 | -14.0% | 15,105 | 0.0% | 0.00% | – |
| Q4 2017 | $107,000 | -0.9% | 15,105 | 0.0% | 0.00% | – |
| Q3 2017 | $108,000 | – | 15,105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $3,107,000 | 1.71% |
| ETF MANAGERS GROUP, LLC | 14,138,998 | $8,534,000 | 0.17% |
| Ikarian Capital, LLC | 948,526 | $584,000 | 0.09% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 318,668 | $196,000 | 0.03% |
| Platform Technology Partners | 45,000 | $28,000 | 0.01% |
| XTX Topco Ltd | 34,476 | $21,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 947,083 | $583,000 | 0.01% |
| Penserra Capital Management LLC | 537,236 | $330,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,070,006 | $2,506,000 | 0.01% |
| Tekla Capital Management LLC | 154,310 | $95,000 | 0.00% |